Found: 29
Select item for more details and to access through your institution.
Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma.
- Published in:
- Life Science Alliance, 2022, v. 5, n. 10, p. 1, doi. 10.26508/lsa.202201445
- By:
- Publication type:
- Article
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Resistance to checkpoint blockade therapy through inactivation of antigen presentation.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01062-w
- By:
- Publication type:
- Article
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.
- Published in:
- Nature Communications, 2016, v. 7, n. 1, p. 10582, doi. 10.1038/ncomms10582
- By:
- Publication type:
- Article
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 581, p. 1, doi. 10.1126/scitranslmed.abd8636
- By:
- Publication type:
- Article
One Hippo and many masters: differential regulation of the Hippo pathway in cancer.
- Published in:
- Biochemical Society Transactions, 2014, v. 42, n. 4, p. 816, doi. 10.1042/BST20140030
- By:
- Publication type:
- Article
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
- Published in:
- Nature, 2012, v. 487, n. 7408, p. 500, doi. 10.1038/nature11183
- By:
- Publication type:
- Article
Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 5, p. 1, doi. 10.15252/emmm.201708446
- By:
- Publication type:
- Article
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 8, p. 1011, doi. 10.15252/emmm.201607156
- By:
- Publication type:
- Article
Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 7, p. 3512, doi. 10.1245/s10434-020-09384-8
- By:
- Publication type:
- Article
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
- Published in:
- Nature Genetics, 2015, v. 47, n. 3, p. 250, doi. 10.1038/ng.3218
- By:
- Publication type:
- Article
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5<sup>−/−</sup> mice.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09525-y
- By:
- Publication type:
- Article
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26299-4
- By:
- Publication type:
- Article
Clinical Profiling of BCL-2 Family Members in the Setting of BRAF Inhibition Offers a Rationale for Targeting <i>De Novo</i> Resistance Using BH3 Mimetics.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101286
- By:
- Publication type:
- Article
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.
- Published in:
- Nature, 2013, v. 504, n. 7478, p. 138, doi. 10.1038/nature12688
- By:
- Publication type:
- Article
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8<sup>+</sup> T-cell infiltration into tumors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31713-6
- By:
- Publication type:
- Article
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29541-9
- By:
- Publication type:
- Article
Wnt5 A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.
- Published in:
- Pigment Cell & Melanoma Research, 2015, v. 28, n. 2, p. 184, doi. 10.1111/pcmr.12330
- By:
- Publication type:
- Article
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
- Published in:
- Journal of Clinical Investigation, 2016, v. 126, n. 5, p. 1834, doi. 10.1172/JCI82661
- By:
- Publication type:
- Article
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 4, p. 1459, doi. 10.1172/JCI78954
- By:
- Publication type:
- Article
MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies.
- Published in:
- Clinical Chemistry, 2024, v. 70, n. 2, p. 434, doi. 10.1093/clinchem/hvad203
- By:
- Publication type:
- Article
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17739-8
- By:
- Publication type:
- Article
MITF Modulates Therapeutic Resistance through EGFR Signaling.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 7, p. 1863, doi. 10.1038/jid.2015.105
- By:
- Publication type:
- Article
BAP1 Has a Survival Role in Cutaneous Melanoma.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 4, p. 1089, doi. 10.1038/jid.2014.528
- By:
- Publication type:
- Article
A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression.
- Published in:
- Thyroid, 2014, v. 24, n. 8, p. 1241, doi. 10.1089/thy.2013.0680
- By:
- Publication type:
- Article
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140310
- By:
- Publication type:
- Article
Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy.
- Published in:
- Molecular Systems Biology, 2019, v. 15, n. 3, p. N.PAG, doi. 10.15252/msb.20188323
- By:
- Publication type:
- Article